The surgeon implanted a vicmo 12.6 -07.50d implantable collamer lens into the patient's right eye (od) on (b)(6) 2022.Concomitant ovd and delivery system information was not provided.Onset of toxic anterior segment syndrome (tass) on noted on day 1.The patient was treated with medication including: "hormone, nsaid, immunosuppressor".The lens was explanted ~3 months later on (b)(6) 2022.The reporter indicates the problem resolved and the cause of the event was unknown.Additional information has been requested but none has been forthcoming.
|
H6 - work order search: no similar complaint was reported for units within the same lot.H11: manufacturer narrative: based on the listed medications the patient may have had autoimmune or chronic disease, which could pose for inflammation of the eye.A review of the device labeling (dfu) was completed.Under precautions for use, precautions for use (apply with caution on the following patients) (18) others, cases where the doctor has judged that the application should be done with caution due to systemic or ophthalmological reasons.The dfu states potential adverse events may require secondary surgery.The dfu provides the surgeon instruction for complete ovd removal.Precaution: (6) after inserting this product, aspirate the viscoelastic substance completely from inside the eye.Do not use highly viscous viscoelastic substances that are difficult to aspirate completely.Toxic anterior segment syndrome (tass) is an acute sterile postoperative inflammation that can occur after uncomplicated or complicated intraocular surgery.While improper sterilization and contamination of surgical instruments remains the most common risk factor associated with tass, ocular viscoelastic, and improper preparation of antibiotics for intracameral injection may also lead to tass.An exact cause could not be determined as the event could be multifactorial in nature including patient and/or procedure related factors.Claim#: (b)(4).
|